ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CYTO Altamira Therapeutics Ltd

1.58
-0.06 (-3.66%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Altamira Therapeutics Ltd CYTO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.06 -3.66% 1.58 23:00:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.62 1.60 1.66 1.64 1.64
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202407:47GLOBEAltamira Therapeutics Announces Filing of Provisional Patent..
24/4/202407:47GLOBEAltamira Therapeutics Announces Publication of Positive..
10/4/202407:00GLOBEAltamira Therapeutics Provides Business Update, Reports Full..
04/4/202407:45GLOBEAltamira Therapeutics to Host Full Year 2023 Financial..
25/3/202407:47GLOBEAltamira Therapeutics Announces Collaboration with..
07/2/202407:47GLOBEAltamira Therapeutics’ Peptide-Based Delivery Platform Shown..
24/1/202407:47GLOBEAltamira Therapeutics Files Second Provisional Patent..
22/1/202416:02EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
21/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202415:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202415:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/1/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202416:02EDGAR2Form F-3 - Registration statement by foreign private issuers
08/1/202407:47GLOBEAltamira Therapeutics to Present at 3rd Annual mRNA-Based..
29/12/202307:47GLOBEAltamira Therapeutics Regains Compliance with Nasdaq Minimum..
11/12/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202307:00GLOBEAltamira Therapeutics Provides Investor and Business Update
08/12/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202311:54GLOBEAltamira Therapeutics to Host Investor & Business Update..
29/11/202309:20GLOBEAltamira Therapeutics Regains Compliance with Nasdaq Minimum..
22/11/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202308:04GLOBEAltamira Therapeutics Announces Partial Spin-Off of Bentrio®..
10/11/202307:47GLOBEAltamira Therapeutics Announces European Patent Office..
31/10/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/9/202307:47GLOBEAltamira Therapeutics Reports Additional Significant..
12/9/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202306:30GLOBEAltamira Therapeutics Provides Business Update and First..
06/9/202307:47GLOBEAltamira Therapeutics to Host First Half 2023 Financial..
23/8/202307:47GLOBEAltamira Therapeutics to Present at H.C. Wainwright 25th..
21/8/202306:31EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
28/7/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/7/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/7/202307:47GLOBEAltamira Therapeutics and Pharma Nordic Collaborate for..
17/7/202307:47GLOBEAltamira Therapeutics Announces Publication of Positive..
11/7/202307:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/7/202315:14EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/7/202307:47GLOBEAltamira Therapeutics Announces Collaboration with Heqet..
30/6/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

Delayed Upgrade Clock